FDA orders surgical mesh makers to study risks

New York Times

The Food and Drug Administration issued an order requiring makers of implantable surgical mesh used to treat urinary incontinence in women to study its risks.

Letter
to the
Editor

Send us a letter

Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

Recommended for You
U.S. Food and Drug Administration (FDA)
Upcoming FDA draft on pulse oximetry's racial bias draws questions
Most Popular
1
Police arrest person of interest in UnitedHealthcare CEO killing
2
Meet the 100 Most Influential People in Healthcare in 2024
3
UnitedHealthcare CEO’s killing unleashes rage against insurers
4
Rural providers beg employers: No retirees in Medicare Advantage
5
When CMS takes aim at the worst nursing homes, it often misses